Revelation Pharma, a US-based national network of 503A and 503B compounding pharmacies, announced on Thursday its acquisition of Acacia Apothecary & Wellness, a compounding pharmacy serving Tucson, Arizona.
According to Revelation, this acquisition expands its footprint and strengthens its expertise in hormone therapy, women's health, and personalised medicine.
Founded in 2014 by Justin and Heather Brock, Acacia Apothecary has two Tucson locations and customers across both human and veterinary medicine.
As part of the acquisition, Justin Brock, PharmD, will join Revelation Pharma as an operational consultant. Brock was recently named a Fellow of the Alliance for Pharmacy Compounding (APC), and is an active advocate for advancing compounding standards and access.
POLYTECH Health & Aesthetics announces Poland expansion
Santhera Pharmaceuticals signs Gulf region distribution agreement with Uniphar
Novo Nordisk expands legal action over compounded 'semaglutide'
Neuraxpharm launches Neuraxpharm Australia
OncoZenge selects Meribel Pharma as CDMO for Phase 3 BupiZenge project
Fridays nominated for World Out of Home awards for weight loss campaign
Physiomics expands into biometrics with two contract wins and new division head
DELFI Diagnostics CTO receives 2025 Most Influential Women in Bay Area Business recognition
Clario acquires imaging provider NeuroRx
Healthcare Holding Schweiz AG acquires Effectum CH-Rep AG to expand services
iOncologi acquires TargImmune Therapeutics
Zydus enters exclusive talks to acquire majority stake in Amplitude Surgical
Adcendo's ADCE-T02 Phase I study IND application receives US FDA approval